AdaptHealth (NASDAQ:AHCO) Announces Earnings Results, Misses Expectations By $0.06 EPS

AdaptHealth (NASDAQ:AHCO) announced its quarterly earnings data on Tuesday. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06), Briefing.com reports. The business had revenue of $805.98 million for the quarter, compared to analyst estimates of $802.62 million. AdaptHealth had a negative net margin of 21.45% and a positive return on equity of 8.47%. The business’s revenue was up 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.16 earnings per share. AdaptHealth updated its FY 2024 guidance to EPS.

AdaptHealth Stock Performance

Shares of AHCO traded up $0.42 during trading hours on Wednesday, hitting $9.08. The stock had a trading volume of 2,385,726 shares, compared to its average volume of 1,072,693. The firm has a 50-day moving average price of $10.57 and a 200 day moving average price of $9.81. AdaptHealth has a fifty-two week low of $6.37 and a fifty-two week high of $15.37. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of -1.72, a PEG ratio of 0.76 and a beta of 1.10. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.11 and a current ratio of 1.33.

Wall Street Analysts Forecast Growth

Separately, Truist Financial restated a “buy” rating and set a $13.00 target price on shares of AdaptHealth in a research report on Wednesday, May 15th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, AdaptHealth presently has an average rating of “Hold” and a consensus target price of $10.70.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.